349 related articles for article (PubMed ID: 25935002)
21. Interleukin 6 induces overexpression of the sarcolemmal utrophin in neonatal mdx skeletal muscle.
Fujimori K; Itoh Y; Yamamoto K; Miyagoe-Suzuki Y; Yuasa K; Yoshizaki K; Yamamoto H; Takeda S
Hum Gene Ther; 2002 Mar; 13(4):509-18. PubMed ID: 11874629
[TBL] [Abstract][Full Text] [Related]
22. Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice.
Odom GL; Gregorevic P; Allen JM; Finn E; Chamberlain JS
Mol Ther; 2008 Sep; 16(9):1539-45. PubMed ID: 18665159
[TBL] [Abstract][Full Text] [Related]
23. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.
Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA
Neurogenetics; 2006 May; 7(2):81-91. PubMed ID: 16525850
[TBL] [Abstract][Full Text] [Related]
24. Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.
Isaac C; Wright A; Usas A; Li H; Tang Y; Mu X; Greco N; Dong Q; Vo N; Kang J; Wang B; Huard J
J Orthop Res; 2013 Mar; 31(3):343-9. PubMed ID: 23097179
[TBL] [Abstract][Full Text] [Related]
25. iNOS expression in dystrophinopathies can be reduced by somatic gene transfer of dystrophin or utrophin.
Louboutin JP; Rouger K; Tinsley JM; Halldorson J; Wilson JM
Mol Med; 2001 May; 7(5):355-64. PubMed ID: 11474581
[TBL] [Abstract][Full Text] [Related]
26. Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin.
Li D; Bareja A; Judge L; Yue Y; Lai Y; Fairclough R; Davies KE; Chamberlain JS; Duan D
J Cell Sci; 2010 Jun; 123(Pt 12):2008-13. PubMed ID: 20483958
[TBL] [Abstract][Full Text] [Related]
27. Cathepsin S Contributes to the Pathogenesis of Muscular Dystrophy in Mice.
Tjondrokoesoemo A; Schips TG; Sargent MA; Vanhoutte D; Kanisicak O; Prasad V; Lin SC; Maillet M; Molkentin JD
J Biol Chem; 2016 May; 291(19):9920-8. PubMed ID: 26966179
[TBL] [Abstract][Full Text] [Related]
28. Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiency.
Baban D; Davies KE
Neuromuscul Disord; 2008 Mar; 18(3):239-47. PubMed ID: 18343112
[TBL] [Abstract][Full Text] [Related]
29. The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice.
Di Certo MG; Corbi N; Strimpakos G; Onori A; Luvisetto S; Severini C; Guglielmotti A; Batassa EM; Pisani C; Floridi A; Benassi B; Fanciulli M; Magrelli A; Mattei E; Passananti C
Hum Mol Genet; 2010 Mar; 19(5):752-60. PubMed ID: 19965907
[TBL] [Abstract][Full Text] [Related]
30. Marginal level dystrophin expression improves clinical outcome in a strain of dystrophin/utrophin double knockout mice.
Li D; Yue Y; Duan D
PLoS One; 2010 Dec; 5(12):e15286. PubMed ID: 21187970
[TBL] [Abstract][Full Text] [Related]
31. Functional substitution by TAT-utrophin in dystrophin-deficient mice.
Sonnemann KJ; Heun-Johnson H; Turner AJ; Baltgalvis KA; Lowe DA; Ervasti JM
PLoS Med; 2009 May; 6(5):e1000083. PubMed ID: 19478831
[TBL] [Abstract][Full Text] [Related]
32. Increasing muscle contractility through low-frequency stimulation alters tibial bone geometry and reduces bone strength in
Chan AS; Hardee JP; Blank M; Cho EH; McGregor NE; Sims NA; Lynch GS
J Appl Physiol (1985); 2023 Jul; 135(1):77-87. PubMed ID: 37262103
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial hydrogen sulfide supplementation improves health in the
Ellwood RA; Hewitt JE; Torregrossa R; Philp AM; Hardee JP; Hughes S; van de Klashorst D; Gharahdaghi N; Anupom T; Slade L; Deane CS; Cooke M; Etheridge T; Piasecki M; Antebi A; Lynch GS; Philp A; Vanapalli SA; Whiteman M; Szewczyk NJ
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33627403
[TBL] [Abstract][Full Text] [Related]
34. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.
Rafael JA; Tinsley JM; Potter AC; Deconinck AE; Davies KE
Nat Genet; 1998 May; 19(1):79-82. PubMed ID: 9590295
[TBL] [Abstract][Full Text] [Related]
35. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
36. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A
Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755
[TBL] [Abstract][Full Text] [Related]
37. Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice.
van Putten M; Hulsker M; Young C; Nadarajah VD; Heemskerk H; van der Weerd L; 't Hoen PA; van Ommen GJ; Aartsma-Rus AM
FASEB J; 2013 Jun; 27(6):2484-95. PubMed ID: 23460734
[TBL] [Abstract][Full Text] [Related]
38. Cardiac and Skeletal Muscle Pathology in the D2/mdx Mouse Model and Caveats Associated with the Quantification of Utrophin.
Kennedy TL; Dugdale HF
Methods Mol Biol; 2023; 2587():55-66. PubMed ID: 36401024
[TBL] [Abstract][Full Text] [Related]
39. CT-GalNAc transferase overexpression in adult mice is associated with extrasynaptic utrophin in skeletal muscle fibres.
Durko M; Allen C; Nalbantoglu J; Karpati G
J Muscle Res Cell Motil; 2010 Sep; 31(3):181-93. PubMed ID: 20706865
[TBL] [Abstract][Full Text] [Related]
40. Utrophin upregulation in Duchenne muscular dystrophy.
Hirst RC; McCullagh KJ; Davies KE
Acta Myol; 2005 Dec; 24(3):209-16. PubMed ID: 16629055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
